Literature DB >> 15906176

Comparison of molecular mobility in the glassy state between amorphous indomethacin and salicin based on spin-lattice relaxation times.

Katsuhiko Masuda1, Sachio Tabata, Yasuyuki Sakata, Tetsuo Hayase, Etsuo Yonemochi, Katsuhide Terada.   

Abstract

PURPOSE: The purpose of the current study was to evaluate the molecular mobility of amorphous indomethacin and salicin in the relaxed glassy state based on spin-lattice relaxation times (T(1c)) and to clarify the effects of molecular mobility on their physical stability.
METHODS: Pulverized glassy amorphous indomethacin and salicin samples were completely relaxed, and the T(1c) values were investigated using solid-state (13)C-nuclear magnetic resonance (NMR) at temperatures below the glass transition temperature (T(g)). All NMR spectra were obtained using the T(1c) measurement method combined with variable-amplitude cross-polarization, the Torchia method, and total sideband suppression method.
RESULTS: The T(1c) value of amorphous indomethacin indicated that 73% of carbons were in a state of monodispersive relaxation, suggesting that the amorphous state was relatively homogeneous and restricted, particularly in backbone carbons. On the other hand, 92% of carbons of amorphous salicin exhibited both fast and slow biphasic relaxation. Individual structures of the salicin molecules behaved heterogeneously, and thus the entire molecule showed relatively fast local as well as slow mobility.
CONCLUSIONS: At temperatures below T(g), amorphous salicin had relatively greater molecular mobility than amorphous indomethacin. This difference in the molecular mobility of the two compounds is correlated with their crystallization behavior. Solid-state (13)C NMR provides valuable information on the physical stability of amorphous pharmaceuticals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15906176     DOI: 10.1007/s11095-005-2597-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

Review 1.  Amorphous pharmaceutical solids: preparation, characterization and stabilization.

Authors:  L Yu
Journal:  Adv Drug Deliv Rev       Date:  2001-05-16       Impact factor: 15.470

2.  Interpretation of relaxation time constants for amorphous pharmaceutical systems.

Authors:  S L Shamblin; B C Hancock; Y Dupuis; M J Pikal
Journal:  J Pharm Sci       Date:  2000-03       Impact factor: 3.534

3.  Relationship between the crystallization rates of amorphous nifedipine, phenobarbital, and flopropione, and their molecular mobility as measured by their enthalpy relaxation and (1)H NMR relaxation times.

Authors:  Y Aso; S Yoshioka; S Kojima
Journal:  J Pharm Sci       Date:  2000-03       Impact factor: 3.534

4.  Explanation of the crystallization rate of amorphous nifedipine and phenobarbital from their molecular mobility as measured by (13)C nuclear magnetic resonance relaxation time and the relaxation time obtained from the heating rate dependence of the glass transition temperature.

Authors:  Y Aso; S Yoshioka; S Kojima
Journal:  J Pharm Sci       Date:  2001-06       Impact factor: 3.534

5.  Molecular mobility of the paracetamol amorphous form.

Authors:  P di Martino; G F Palmieri; S Martelli
Journal:  Chem Pharm Bull (Tokyo)       Date:  2000-08       Impact factor: 1.645

6.  Dynamics of pharmaceutical amorphous solids: the study of enthalpy relaxation by isothermal microcalorimetry.

Authors:  Jinsong Liu; Daniel R Rigsbee; Carol Stotz; Michael J Pikal
Journal:  J Pharm Sci       Date:  2002-08       Impact factor: 3.534

7.  Evaluation of different calorimetric methods to determine the glass transition temperature and molecular mobility below T(g) for amorphous drugs.

Authors:  I Weuts; D Kempen; K Six; J Peeters; G Verreck; M Brewster; G Van den Mooter
Journal:  Int J Pharm       Date:  2003-06-18       Impact factor: 5.875

8.  Some physicochemical properties of glassy indomethacin.

Authors:  E Fukuoka; M Makita; S Yamamura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-10       Impact factor: 1.645

9.  Microscopic molecular mobility of amorphous AG-041R measured by solid-state 13C NMR.

Authors:  Akiko Koga; Etsuo Yonemochi; Minoru Machida; Yoshinori Aso; Hidetoshi Ushio; Katsuhide Terada
Journal:  Int J Pharm       Date:  2004-05-04       Impact factor: 5.875

10.  Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Authors:  B C Hancock; S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

View more
  6 in total

1.  Solid-State (13)C NMR Delineates the Architectural Design of Biopolymers in Native and Genetically Altered Tomato Fruit Cuticles.

Authors:  Subhasish Chatterjee; Antonio J Matas; Tal Isaacson; Cindie Kehlet; Jocelyn K C Rose; Ruth E Stark
Journal:  Biomacromolecules       Date:  2015-12-24       Impact factor: 6.988

2.  Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns.

Authors:  Simon Bates; George Zografi; David Engers; Kenneth Morris; Kieran Crowley; Ann Newman
Journal:  Pharm Res       Date:  2006-09-22       Impact factor: 4.200

3.  Deconstructing a plant macromolecular assembly: chemical architecture, molecular flexibility, and mechanical performance of natural and engineered potato suberins.

Authors:  Olga Serra; Subhasish Chatterjee; Mercè Figueras; Marisa Molinas; Ruth E Stark
Journal:  Biomacromolecules       Date:  2014-02-25       Impact factor: 6.988

4.  The Role of Configurational Entropy in Amorphous Systems.

Authors:  Kirsten A Graeser; James E Patterson; J Axel Zeitler; Thomas Rades
Journal:  Pharmaceutics       Date:  2010-05-25       Impact factor: 6.321

5.  Exploring molecular reorientations in amorphous and recrystallized felodipine at the microscopic level.

Authors:  A Pajzderska; J Jenczyk; J P Embs; J Wąsicki
Journal:  RSC Adv       Date:  2020-10-08       Impact factor: 4.036

6.  Exploring the molecular reorientations in amorphous rosuvastatin calcium.

Authors:  N M Belozerova; P Bilski; M Jarek; J Jenczyk; S E Kichanov; D P Kozlenko; J Mielcarek; A Pajzderska; J Wąsicki
Journal:  RSC Adv       Date:  2020-09-11       Impact factor: 3.361

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.